Join
Live feed
·
INSIDERFilingvia Quantisnow
Opiant Pharmaceuticals Inc. logo

SEC Form 4: Ruth Matthew R. sold $11,512 worth of shares (1,084 units at $10.62), decreasing direct ownership by 3% to 29,916 units (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPNT (Opiant Pharmaceuticals Inc.) and more on Quantisnow.